1 Tockman, M. S., Anthonisen, N. R., Wright, E. C., and Donithan, M. G. 1987. Airways obstruction and the risk for lung cancer. Ann Intern Med 106:512.
2 Young, R. P., Hopkins, R. J., Christmas, T., Black, P. N., Metcalf, P., and Gamble, G. D. 2009. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 34:380.
3 Fajersztajn, L., Veras, M., Barrozo, L. V., and Saldiva, P. 2013. Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer 13:674.
4 Hecht, S. S. 1999. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194.
5 Wang, C., Xu, J., Yang, L., Xu, Y., Zhang, X., Bai, C., Kang, J., Ran, P., Shen, H., Wen, F., Huang, K., Yao, W., Sun, T., Shan, G., Yang, T., Lin, Y., Wu, S., Zhu, J., Wang, R., Shi, Z., Zhao, J., Ye, X., Song, Y., Wang, Q., Zhou, Y., Ding, L., Chen, Y., Guo, Y., Xiao, F., Lu, Y., Peng, X., Zhang, B., Xiao, D., Chen, C. S., Wang, Z., Zhang, H., Bu, X., An, L., Zhang, S., Cao, Z., Zhan, Q., Yang, Y., Cao, B., Dai, H., Liang, L., and He, J. 2018. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 391:1706.
6 Pardoll, D. M. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252.
7 Lee, M. H., Yanagawa, J., Tran, L., Walser, T. C., Bisht, B., Fung, E., Park, S. J., Zeng, G., Krysan, K., Wallace, W. D., Paul, M. K., Girard, L., Gao, B., Minna, J. D., Dubinett, S. M., and Lee, J. M. 2020. FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells. Am J Transl Res 12:409.
8 Jia, M., Feng, W., Kang, S., Zhang, Y., Shen, J., He, J., Jiang, L., Wang, W., Guo, Z., Peng, G., Chen, G., and Liang, W. 2015. Evaluation of the efficacy and safety of anti-PD-1 and anti-PD-L1 antibody in the treatment of non-small cell lung cancer (NSCLC): a meta-analysis. J Thorac Dis 7:455.
9 Mark, N. M., Kargl, J., Busch, S. E., Yang, G. H. Y., Metz, H. E., Zhang, H., Hubbard, J. J., Pipavath, S. N. J., Madtes, D. K., and Houghton, A. M. 2018. Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer. Am J Respir Crit Care Med 197:325.
10 Kang, X., Li, P., Zhang, C., Zhao, Y., Hu, H., and Wen, G. 2020. The TLR4/ERK/PDL1 axis may contribute to NSCLC initiation. Int J Oncol 57:456.
11 Liu, C. H., Chen, Z., Chen, K., Liao, F. T., Chung, C. E., Liu, X., Lin, Y. C., Keohavong, P., Leikauf, G. D., and Di, Y. P. 2020. Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy. Cancer Res.
12 Shu, J., Lu, W., Yang, K., Zheng, Q., Li, D., Li, Y., Kuang, M., Liu, H., Li, Z., Chen, Y., Zhang, C., Luo, X., Huang, J., Wu, X., Tang, H., and Wang, J. 2018. Establishment and evaluation of chronic obstructive pulmonary disease model by chronic exposure to motor vehicle exhaust combined with lipopolysaccharide instillation. Exp Physiol 103:1532.
13 Li, D., Wang, J., Sun, D., Gong, X., Jiang, H., Shu, J., Wang, Z., Long, Z., Chen, Y., Zhang, Z., Yuan, L., Guan, R., Liang, X., Li, Z., Yao, H., Zhong, N., and Lu, W. 2018. Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in mice. Sci Rep 8:376.
14 Wang, G. Z., Zhang, L., Zhao, X. C., Gao, S. H., Qu, L. W., Yu, H., Fang, W. F., Zhou, Y. C., Liang, F., Zhang, C., Huang, Y. C., Liu, Z., Fu, Y. X., and Zhou, G. B. 2019. The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy. Nat Commun 10:1125.
15 Chen, S., Li, D., Zhang, H., Yu, D., Chen, R., Zhang, B., Tan, Y., Niu, Y., Duan, H., Mai, B., Yu, J., Luan, T., Chen, L., Xing, X., Li, Q., Xiao, Y., Dong, G., Aschner, M., Zhang, R., Zheng, Y., and Chen, W. 2019. The development of a cell-based model for the assessment of carcinogenic potential upon long-term PM2.5 exposure. Environ Int 131:104943.
16 Xu, Z., Wu, H., Zhang, H., Bai, J., and Zhang, Z. 2020. Interleukins 6/8 and cyclooxygenase-2 release and expressions are regulated by oxidative stress-JAK2/STAT3 signaling pathway in human bronchial epithelial cells exposed to particulate matter </=2.5 mum. J Appl Toxicol 40:1210.
17 Narayanapillai, S. C., Han, Y. H., Song, J. M., Kebede, M. E., Upadhyaya, P., and Kassie, F. 2020. Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis. Carcinogenesis 41:1518.
18 Shu, J., Li, D., Ouyang, H., Huang, J., Long, Z., Liang, Z., Chen, Y., Zheng, Q., Kuang, M., Tang, H., Wang, J., and Lu, W. 2017. Comparison and evaluation of two different methods to establish the cigarette smoke exposure mouse model of COPD. Sci Rep 7:15454.
19 Li, D., Sun, D., Yuan, L., Liu, C., Chen, L., Xu, G., Shu, J., Guan, R., Xu, J., Li, Y., Yi, G., Yao, H., Zhong, N., Wang, J., and Lu, W. 2020. Sodium tanshinone IIA sulfonate protects against acute exacerbation of cigarette smoke-induced chronic obstructive pulmonary disease in mice. Int Immunopharmacol 81:106261.
20 Shao, M. X., Ueki, I. F., and Nadel, J. A. 2003. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci U S A 100:11618.
21 Aldarouish, M., Su, X., Qiao, J., Gao, C., Chen, Y., Dai, A., Zhang, T., Shu, Y., and Wang, C. 2019. Immunomodulatory effects of chemotherapy on blood lymphocytes and survival of patients with advanced non-small cell lung cancer. Int J Immunopathol Pharmacol 33:2058738419839592.
22 Kim, G. J., Lee, J. H., Park, W. J., Lee, H. W., Hwang, I. S., and Lee, D. H. 2019. The Prognostic Value of Measuring PD-L1 mRNA Expression Levels in Surgically Resected Non-Small Cell Lung Cancer. Ann Clin Lab Sci 49:317.
23 Chen, N., Fang, W., Lin, Z., Peng, P., Wang, J., Zhan, J., Hong, S., Huang, J., Liu, L., Sheng, J., Zhou, T., Chen, Y., Zhang, H., and Zhang, L. 2017. KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma. Cancer Immunol Immunother 66:1175.
24 McKendry, R. T., Spalluto, C. M., Burke, H., Nicholas, B., Cellura, D., Al-Shamkhani, A., Staples, K. J., and Wilkinson, T. M. 2016. Dysregulation of Antiviral Function of CD8(+) T Cells in the Chronic Obstructive Pulmonary Disease Lung. Role of the PD-1-PD-L1 Axis. Am J Respir Crit Care Med 193:642.
25 Shima, T., Shimoda, M., Shigenobu, T., Ohtsuka, T., Nishimura, T., Emoto, K., Hayashi, Y., Iwasaki, T., Abe, T., Asamura, H., and Kanai, Y. 2020. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma. Cancer Sci 111:727.
26 Lim, J. U. and Yoon, H. K. 2020. Potential predictive value of change in inflammatory cytokines levels subsequent to initiation of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer. Cytokine 138:155363.
27 Guan, R., Wang, J., Li, D., Li, Z., Liu, H., Ding, M., Cai, Z., Liang, X., Yang, Q., Long, Z., Chen, L., Liu, W., Sun, D., Yao, H., and Lu, W. 2020. Hydrogen sulfide inhibits cigarette smoke-induced inflammation and injury in alveolar epithelial cells by suppressing PHD2/HIF-1alpha/MAPK signaling pathway. Int Immunopharmacol 81:105979.
28 Park, E. J., Park, Y. J., Lee, S. J., Lee, K., and Yoon, C. 2019. Whole cigarette smoke condensates induce ferroptosis in human bronchial epithelial cells. Toxicol Lett 303:55.
29 Blanchet, S., Ramgolam, K., Baulig, A., Marano, F., and Baeza-Squiban, A. 2004. Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol 30:421.
30 Wu, J., Shi, Y., Asweto, C. O., Feng, L., Yang, X., Zhang, Y., Hu, H., Duan, J., and Sun, Z. 2017. Fine particle matters induce DNA damage and G2/M cell cycle arrest in human bronchial epithelial BEAS-2B cells. Environ Sci Pollut Res Int 24:25071.
31 Miller, A., Brooks, G. D., McLeod, L., Ruwanpura, S., and Jenkins, B. J. 2015. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis. Oncogene 34:1510.
32 Zhang, X., Zeng, Y., Qu, Q., Zhu, J., Liu, Z., Ning, W., Zeng, H., Zhang, N., Du, W., Chen, C., and Huang, J. A. 2017. PD-L1 induced by IFN-gamma from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer. Int J Clin Oncol 22:1026.
33 Li, Y. M., Yu, J. M., Liu, Z. Y., Yang, H. J., Tang, J., and Chen, Z. N. 2019. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8(+) T Cells in Non-Small Cell Lung Cancer. Int J Mol Sci 20.
34 Seki, N., Kan, O. K., Matsumoto, K., Fukuyama, S., Hamano, S., Tonai, K., Ota, K., Inoue, H., and Nakanishi, Y. 2017. Interleukin-22 attenuates double-stranded RNA-induced upregulation of PD-L1 in airway epithelial cells via a STAT3-dependent mechanism. Biochem Biophys Res Commun 494:242.